Imatinib mesylate (Gleevec) downregulates telomerase activity and inhibits proliferation in telomerase-expressing cell lines

por Uziel, O, Fenig, E, Nordenberg, J, Beery, E, Reshef, H, Sandbank, J, Birenbaum, M, Bakhanashvili, M, Yerushalmi, R, Luria, D, Lahav, M
Publicado 2005

P1108: HIGH COMPLETE RESPONSE RATE FOLLOWING POINT-OF-CARE ANTI CD19 CAR T-CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA

por Fried, S., Besser, M. J., Shkury, E., Yerushalmi, R., Shem-Tov, N., Danylesko, I., Jacoby, E., Itzhaki, O., Shouval, R., Kedmi, M., Shimoni, A., Nagler, A., Avigdor, A.
Publicado 2022